Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Gilead Sciences, Inc.

Gilead Sciences, Inc. (GIS.DE) Stock Overview

Explore Gilead Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

GIS.DE●XETRA
HealthcareDrug Manufacturers - General
€128.52
€3.14(2.38%)
German Market is Open · 17:08

Gilead Sciences, Inc. (GIS.DE)

Meyka AI Score

Z

Key Financials

Market Cap159.8B
P/E Ratio-55.71
EPS (TTM)$-1.24
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$137.45
3 Months$128.06
1 Year Target$135.36

GIS.DE Stock Analysis & Investment Overview (XETRA)

Our AI-powered analysis of Gilead Sciences, Inc. (XETRA: GIS.DE) gives investors deep insight into how the stock performs on the XETRA exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Gilead Sciences, Inc.'s XETRA-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GIS.DE on the XETRA shows an RSI of 50.02, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $135.36 for the XETRA listing.

Key metrics behind Gilead Sciences, Inc.'s XETRA-traded stock include a P/E ratio of -55.71 and a market capitalization of 159.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of GIS.DE on the XETRA.

Price Performance (XETRA: GIS.DE)

1-Day Change
-2.25%
5-Day Change
-1.94%
1-Month Change
-0.28%
3-Month Change
13.49%
6-Month Change
6.08%
Year-to-Date (YTD) Change
24.47%
1-Year Change
37.29%
3-Year Change
81.52%
5-Year Change
119.96%
All-Time (Max) Change
9027.66%

Contact Information

https://www.gilead.com
650 574 3000
333 Lakeside Drive, Foster City, CA, 94404

Company Facts

170,000 Employees
IPO DateJan 3, 2000
CountryUS
Actively Trading

Frequently Asked Questions